Company profile
Itonis, Inc.
OTC: ITNS · Healthcare · Medical - Pharmaceuticals
#1157 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
25DFH 22DQ —GM 26SS 37
v0.1 · 45/100 weight · provisional
↑ return on assets, listing tenure · ↓ balance-sheet leverage, operating margin
Methodology →Revenue TTM
$74
Rev growth YoY (TTM)
-71.1%
Net income (FY)
-$11.3k
Employees
3
as of 2026-08-26
Market cap
$457.0k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$153$1532025
Net income-$11.3k-$11.3k2025
Operating income-$11.3k-$11.3k2025
Total assets$136.4k$136.4k2025
Liabilities$1.3M$1.3M2025
Equity-$1.1M-$1.1M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Itonis, Inc.’s revenue?
Itonis, Inc. booked $153 in FY2025 revenue, contracting 56% year over year — slower than 83% of Healthcare companies we track, at a -7415.0% net margin.
Peers · Healthcare
ProText Mobility, Inc.——Cannonau Corp.——Ludwig Enterprises, Inc.12DGlobeStar Therapeutics Corporation——VMS Rehab Systems, Inc.——Goldenwell Biotech, Inc.16DNeighbors
Orange →Key facts
CEOMark H. Cheung
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersLaguna Hills, CA
ExchangeOTC: ITNS
Employees3
IPO date2007-02-21
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.